Search
Richard Lipscombe expects the recently commercialised testing kit to be in high demand. Photo: Gabriel Oliveira

Proteomics kit fit for market

It has taken over 15 years, but Perth-based medical technology company Proteomics International is now launching a commercial product targeted at the US.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/19

1 year TSR5 year TSR
147thProteomics International Laboratories19%
243rdConnected IO0%-24%
425thBotanix Pharmaceuticals-28%102%
655thSyntonic-56%-12%
733rdThred-66%-38%
726 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

16/04/18
$0 Other
16/04/18
$0 Other
06/04/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

129th↓Proteomics International Laboratories$2.1m
136th↑Thred$1.8m
137th↑Syntonic$1.8m
139th↑Botanix Pharmaceuticals$1.8m
140th↓Connected IO$1.7m
228 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer